Clincosm LogoSign in Get a demo

diabetes

Showing NaN - NaN of 86
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/insulin aspart
  • insulin glargine
  • Fresno, California
  • +64 more
Feb 9, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • insulin aspart
  • Fresno, California
  • +68 more
Jan 30, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, exenatide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +125 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, metformin)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +165 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, insulin detemir, metformin)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Alexander City, Alabama
  • +232 more
Jan 25, 2017

Diabetes, Diabetes, Type 2 Trial in Mexico, Puerto Rico, United States (liraglutide, glimepiride, )

Terminated
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Concord, California
  • +116 more
Jan 24, 2017

Diabetes, Diabetes, Type 2 Trial in United States (insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • Huntsville, Alabama
  • +44 more
Jan 20, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Little Rock, Arkansas
  • +181 more
Jan 16, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Northridge, California
  • +98 more
Jan 20, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin aspart, insulin detemir)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin aspart
  • insulin detemir
  • Birmingham, Alabama
  • +66 more
Jan 2, 2017

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (repaglinide and metformin combination tablet, rosiglitazone and

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • repaglinide and metformin combination tablet
  • rosiglitazone and metformin combination tablet
  • Vestavia, Alabama
  • +102 more
Feb 9, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Phoenix, Arizona
  • +119 more
Dec 15, 2016

Diabetes, Diabetes, Type 2 Trial in Canada, Puerto Rico, United States (insulin detemir, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • +2 more
  • Birmingham, Alabama
  • +77 more
Jan 30, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • insulin glargine
  • Greenbrae, California
  • +95 more
Jan 26, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin detemir, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin detemir
  • +2 more
  • Anaheim, California
  • +80 more
Jan 26, 2017

Diabetes, Diabetes, Type 2 Trial in Canada, United States (liraglutide, rosiglitazone, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Goodyear, Arizona
  • +88 more
Jan 24, 2017

Diabetes, Diabetes, Type 2 Trial in United States (biphasic insulin aspart, pioglitazone, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • biphasic insulin aspart
  • +2 more
  • Birmingham, Alabama
  • +72 more
Jan 10, 2017

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (biphasic insulin aspart, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • biphasic insulin aspart
  • insulin glargine
  • Birmingham, Alabama
  • +72 more
Jan 10, 2017

Diabetes, Diabetes, Type 1 Trial in Atlanta (Faster-acting insulin aspart, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Faster-acting insulin aspart
  • insulin aspart
  • Atlanta, Georgia
    Novo Nordisk Investigational Site
Jan 6, 2017

Diabetes, Diabetes, Type 2 Trial in United States (biphasic insulin aspart, insulin glargine, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • biphasic insulin aspart
  • +3 more
  • Concord, California
  • +26 more
Jan 6, 2017

Diabetes, Diabetes, Type 1 Trial in United States (insulin lispro, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin lispro
  • insulin aspart
  • Mobile, Alabama
  • +51 more
Dec 21, 2016

Diabetes, Diabetes, Type 1 Trial in United States (insulin human, insulin lispro, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin human
  • +2 more
  • Birmingham, Alabama
  • +75 more
Dec 21, 2016

Diabetes Trial in Worldwide (Ro 205-2349)

Completed
  • Diabetes
  • Ro 205-2349
  • Huntsville, Alabama
  • +116 more
Aug 23, 2016

Diabetes Trial in Argentina, Peru, United States (Placebo, TAK-875)

Terminated
Has Results
  • Diabetes
  • Birmingham, Alabama
  • +85 more
Apr 24, 2016

Constipation, Diabetes Trial in Atlanta (Lubiprostone, Placebo)

Completed
Has Results
  • Constipation
  • Diabetes
  • Atlanta, Georgia
  • +1 more
Feb 17, 2016